Triple Strength Omega-3 150c

540 mg EPA + 360 mg DHA per capsule

Pack size 150 caps

TGA listing AUST L 374067

GTIN 09346710000796

Contains: fish / seafood, soy, sulfites

Supplement Club price $53.00

RRP $75.96 Save $22.96 (30%)

Stock is sourced through an established Australian practitioner wholesaler. Checked 11 June 2026.

View cart

Dave's note

Why I like it

A strong default capsule option when someone has already been advised to use a higher EPA/DHA intake. Good concentration, practical capsule burden, and strong value in the current supplier cache.

It is a practical high-strength capsule: 900 mg EPA+DHA per capsule means a 3 g EPA+DHA/day target is roughly 4 capsules rather than a high capsule burden.
The label uses concentrated fish omega-3 triglycerides, which is the omega-3 form I prefer to consider first when the price is competitive.
It is currently good value against RRP, so it works as a sensible default capsule option before moving someone to a liquid fish oil.
The TGA listing, transparent allergen flags, and clear EPA/DHA numbers make it easy to document and explain.

How I take it

When I am using this as my omega-3 capsule option, I take 4 capsules/day with food: usually 2 capsules with a main meal and 2 capsules with another meal.
That gives about 3.6 g/day combined EPA+DHA, which is close to the high-dose EPA/DHA range I am interested in for lipid and cardiovascular-risk discussions.
I take it with food because EPA/DHA absorption is better with meals, and splitting the dose is also more comfortable than taking all 4 capsules at once.
I treat this as a targeted protocol rather than a default forever-dose: I would reassess against diet, omega-3 status, triglycerides, medications, bleeding risk, and any upcoming procedure.

This is my personal protocol logic, not a blanket client instruction. Client dose still needs to be individualised.

Studies that informed my choice

Association Between Omega-3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose-Response Meta-Analysis of Randomized Controlled Trials Meta-analysis · Wang et al. 2023 Dose-response evidence is why I think in grams of EPA+DHA. A 2023 continuous dose-response meta-analysis of randomized trials found combined omega-3 intake lowered triglycerides in a dose-responsive pattern. This is why I calculate the actual EPA+DHA delivered, rather than treating all fish oil capsules as equivalent. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis Systematic review + meta-analysis · Khan et al. 2021 Cardiovascular outcome evidence keeps the claim conservative. A 2021 meta-analysis of 38 RCTs reported modest cardiovascular outcome benefits overall, with stronger signals for EPA-only trials than combined EPA+DHA. This informs my caution: I like this as a strong EPA+DHA capsule, but I would not position it as equivalent to prescription EPA for high-risk cardiovascular indications. The influence of dietary and supplemental omega-3 fatty acids on the omega-3 index: A scoping review Scoping review · Dempsey et al. 2023 Omega-3 index data supports using a concentrated triglyceride-form EPA+DHA product. A 2023 scoping review found that triglyceride-form EPA+DHA at roughly 1,000-1,500 mg/day for at least 12 weeks was a practical range for improving omega-3 index. This supports preferring a concentrated triglyceride-form product when value is reasonable. Bioavailability of EPA and DHA in humans - A comprehensive review Comprehensive review · Alijani et al. 2025 Form and meal timing matter for bioavailability. A 2025 comprehensive review of human EPA/DHA bioavailability reinforces that chemical form and delivery method affect uptake. Clinical references also note better absorption when EPA/DHA is taken with food, which is why I take this with meals.

Evidence note: these papers inform the dose, use case, formulation, and timing logic. They are not brand-specific clinical outcome evidence.

Formula

Ingredient panel

Ingredient Per capsule

Concentrated fish omega-3 triglycerides 1.5 g per capsule

Eicosapentaenoic acid (EPA) 540 mg per capsule

Docosahexaenoic acid (DHA) 360 mg per capsule

Does not contain eggmilkpeanutcorntree nutsglutenlactoseartificial colours or flavours

Dosage & warnings

How the label frames use

Dosage

General health and wellbeing: adults and children over 12 years take 1 capsule daily with food.
Muscle health, memory and circulation: take 2 capsules daily with food.
Joint health: take 2-3 capsules daily with food.
Or take as directed by a health professional.

Warnings

Contains fish products and sulfites.
Advise your doctor of any medicine you take during pregnancy, particularly in your first trimester.
Always read the label and follow the directions for use.
Dietary supplements should not replace a balanced diet.
If symptoms persist, talk to your health professional.

Allergen note: contains fish / seafood, soy, sulfites.

Downloads

Regulatory and manufacturer links

TGA ARTG record - AUST L 374067 Regulatory listing
TGA public summary Active ingredients, excipients, warnings, and permitted indications
Herbs of Gold product page Manufacturer source

TGA public summary includes the ARTG listing, permitted indications, warnings, active ingredients, and excipients.

Summary

Product snapshot

For a 3 g EPA+DHA/day protocol, the practical dose is 4 capsules/day, giving about 3.6 g EPA+DHA. Suitability still depends on medications, bleeding risk, allergy history, and goals.

Contains fish. Check suitability if using anticoagulant or antiplatelet medication, before surgery, during pregnancy, or with fish allergy.

Odourless high-strength fish oil
900 mg EPA+DHA per capsule
Triglyceride-form concentrated fish oil
Traceable Australian practitioner-wholesaler supply

Source note: Herbs of Gold manufacturer information and the TGA public ARTG summary were checked 11 June 2026. Stock is sourced through an established Australian practitioner wholesaler. Product information is general only and does not replace personalised advice.